SFTA2 was identified as a potential disease-free survival prognostic gene in colon cancer and one of the potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma [70, 71]. This evidence concerns the gene SFTA2 and lung adenocarcinoma.